Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

No Thumbnail Available

Files

FAST-Forward_final_08042020.pdf (548.65 KB)
FF Supplementary Appendix_revised_03042020.pdf (5.51 MB)

Embargo End Date

ICR Authors

Sydenham, Mark
 Haviland, Joanne
 Kirby, Anna
 Somaiah, Navita
 Bliss, Judith

Authors

Haviland, J
Sydenham, M
Hopwood, P
Kirby, A
Somaiah, N
Stones, L
Bliss, J
Yarnold, J

Document Type

Journal Article

Date

Date Accepted

2020-04-09

Abstract

Citation

The Lancet

DOI

URI

https://repository.icr.ac.uk/handle/internal/3593

Rights

https://creativecommons.org/licenses/by/4.0

Source Title

Publisher

Elsevier

ISSN

0140-6736

eISSN

Collections

Clinical Studies
Radiotherapy and Imaging

Research Team

Clinical Trials & Statistics Unit
Breast Cancer Radiotherapy
Translational Breast Radiobiology

Notes